Microdose Psychedelic Insights, along with The Conscious Fund, MagicMed Industries, Wake Network, and Empyrean, is pleased to present The Mushroom Conference: A Molecular Masterclass, on November 20th - 22nd.
Toronto, Oct 19, 2020 (Issuewire.com) - Microdose Psychedelic Insights, along with The Conscious Fund, MagicMed Industries, Wake Network, and Empyrean, is pleased to present The Mushroom Conference: A Molecular Masterclass, on November 20th - 22nd.
This three-day virtual conference will feature up to 100 experts in the field, and guide attendees through a scientific deep dive into the dynamic field of psilocybin therapy and functional mushrooms. The third day will be a fun consumer-focused.
The Mushroom Conference will explore mushrooms at the intersection of clinical care, research and investment and feature the world's top researchers, clinicians, companies, advocates and experts. Some overarching areas featured at this conference, aimed predominantly at B2B audiences, include: Advanced mycological research, Medicinal Mushrooms, Mycotoxicology, Food mycology, Fungal biotechnology, Industrial mycology, Medical mycology, Bacterial-fungal interactions, Fungal pathogens, Clinical mycology, Psilocybin research, Psilocybin clinical studies, Psilocybin-assisted therapies, Business & Opportunities, Investment, Consumer brands and Innovations.
Guest speakers include: Dr. Joseph Tucker Chief Executive Officer, MagicMed Industries Inc., Marshall Tyler Director of Research, Field Trip Psychedelics Inc., Dr. Jillian Hagel COO, MagicMed Industries Inc., Jackie von Salm, PhD, Co-Founder and CSO at Psilera Bioscience, Mohammad Ebrahimzadeh, PhD, MSc Medical Advisor, Dvija Phytoceutical Corp, Dr. Hyder A. Khoja Founder and CSO, Transcendent Therapeutics, Inc, Tonya Papanikolov Founder and CEO of Rainbo, Dustin Robinson Licensed attorney, CPA, and realtor, Founder Mr. Psychedelic Law, Jerry B. Brown, Ph.D. and Julie M. Brown, M.A., L.M.H.C. Coauthors The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity, Paul Austin Founder, CEO Third Wave + Synthesis, Eddie Jacobs Research Fellow, University of Oxford, Associate Professor of Clinical Sciences, among others.
To highlight the rich diversity in the emerging psychedelic medicine space, we are looking to feature female and BIPOC speakers at our events. If you would like to be a speaker, please click here to apply.
Groundbreaking clinical trials have begun to unravel the immense therapeutic potential of psilocybin in the treatment of various debilitating mental health conditions. This rapidly emerging field is undoubtedly opening up unique opportunities for academics, clinicians, and investors alike. This one-of-a-kind conference is designed to introduce attendees of all types to the latest information and thought leadership on the topic of functional mushrooms and psilocybin to facilitate mental health and wellness. With experts and thought leaders hailing from the top companies in the space, you can be sure to enjoy deep insights and commentary at the cutting edge of the psychedelic renaissance.
Sunday is open to Consumers! more details will be announced shortly.
More details and tickets to the event can be found here.
If you are interested in learning about sponsorship opportunities for The Mushroom Conference, please reach out to firstname.lastname@example.org for details.
Microdose Psychedelic Insights
Source :Microdose Psychedelic Insights
This article was originally published by IssueWire. Read the original article here.